Bradley Hargreaves
Chief Operating Officer bei XC Velle Institute, Inc.
Vermögen: 160 256 $ am 31.03.2024
Profil
Bradley Hargreaves is currently the Operations Director & Principal at XC Velle Institute, Inc. and the Director, VP-Technology & Operations at Cell MedX (Canada) Corp.
He previously worked as the Director at Cell MedX Corp.
from 2023 to 2024.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CELL MEDX CORP.
1,81% | 07.02.2024 | 5 341 855 ( 1,81% ) | 160 256 $ | 31.03.2024 |
Aktive Positionen von Bradley Hargreaves
| Unternehmen | Position | Beginn |
|---|---|---|
| XC Velle Institute, Inc. | Chief Operating Officer | 01.01.2009 |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Bradley Hargreaves
| Unternehmen | Position | Ende |
|---|---|---|
| CELL MEDX CORP. | Chief Tech/Sci/R&D Officer | 12.12.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELL MEDX CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| XC Velle Institute, Inc. | |
Cell MedX (Canada) Corp.
Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Health Technology |
